These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 26422187)

  • 1. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.
    Lurain NS; Hanson BA; Hotton AL; Weber KM; Cohen MH; Landay AL
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):134-43. PubMed ID: 26422187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    Gómez-Mora E; Massanella M; García E; Giles D; Bernadó M; Urrea V; Carrillo J; Ouchi D; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C
    PLoS One; 2017; 12(9):e0184433. PubMed ID: 28934217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.
    Freeman ML; Lederman MM; Gianella S
    Curr HIV/AIDS Rep; 2016 Feb; 13(1):10-9. PubMed ID: 26810437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
    Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
    J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
    Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
    J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically Suppressive Antiretroviral Therapy in the ICONA Cohort.
    Vita S; Lichtner M; Marchetti G; Mascia C; Merlini E; Cicconi P; Vullo V; Viale P; Costantini A; DʼArminio Monforte A;
    J Acquir Immune Defic Syndr; 2017 Mar; 74(3):347-352. PubMed ID: 27828874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High CMV IgG antibody levels are associated to a lower CD4+ RESPONSE to antiretroviral therapy in HIV-infected women.
    Giuliano M; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Ciccacci F; Amici R; Marazzi MC; Vella S; Palombi L; Mancinelli S
    J Clin Virol; 2017 Nov; 96():17-19. PubMed ID: 28918126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of humoral responses as a marker of CMV burden in HIV patients on ART requires consideration of T-cell recovery and persistent B-cell activation.
    Brunt SJ; Lee S; D'Orsogna L; Bundell C; Burrows S; Price P
    Dis Markers; 2014; 2014():947432. PubMed ID: 25506120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression.
    Imp BM; Rubin LH; Tien PC; Plankey MW; Golub ET; French AL; Valcour VG
    J Infect Dis; 2017 Jan; 215(1):114-121. PubMed ID: 27789726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short Communication: SCD14 and SCD163 Levels Are Correlated with VACS Index Scores: Initial Data from the Blunted Immune Recovery in CORE Patients with HIV (BIRCH) Cohort.
    Williams B; Livak B; Bahk M; Keating SM; Adeyemi OM
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):144-7. PubMed ID: 26366931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentration of anti-Cytomegalovirus IgG and ischaemic stroke in patients with advanced HIV infection in Malawi.
    Kamtchum-Tatuene J; Al-Bayati Z; Mwandumba HC; Solomon T; Christmas SE; Benjamin LA
    PLoS One; 2018; 13(11):e0208040. PubMed ID: 30481210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.
    Letendre S; Bharti A; Perez-Valero I; Hanson B; Franklin D; Woods SP; Gianella S; de Oliveira MF; Heaton RK; Grant I; Landay AL; Lurain N;
    Clin Infect Dis; 2018 Aug; 67(5):770-777. PubMed ID: 29506084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation.
    Patel EU; Gianella S; Newell K; Tobian AA; Kirkpatrick AR; Nalugoda F; Grabowski MK; Gray RH; Serwadda D; Quinn TC; Redd AD; Reynolds SJ
    AIDS; 2017 Mar; 31(6):807-813. PubMed ID: 28121712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus-specific T-cells are associated with immune senescence, but not with systemic inflammation, in people living with HIV.
    Ballegaard V; Brændstrup P; Pedersen KK; Kirkby N; Stryhn A; Ryder LP; Gerstoft J; Nielsen SD
    Sci Rep; 2018 Feb; 8(1):3778. PubMed ID: 29491459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women.
    Parrinello CM; Sinclair E; Landay AL; Lurain N; Sharrett AR; Gange SJ; Xue X; Hunt PW; Deeks SG; Hodis HN; Kaplan RC
    J Infect Dis; 2012 Jun; 205(12):1788-96. PubMed ID: 22492856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus.
    Ariyanto IA; Estiasari R; Edwar L; Makwana N; Lee S; Price P
    Immunol Invest; 2019 May; 48(4):345-354. PubMed ID: 30422022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
    Parisi SG; Andreis S; Mengoli C; Menegotto N; Cavinato S; Scaggiante R; Andreoni M; Palù G; Basso M; Cattelan AM
    Med Microbiol Immunol; 2018 Aug; 207(3-4):183-194. PubMed ID: 29523966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.
    Castley A; Williams L; James I; Guelfi G; Berry C; Nolan D
    PLoS One; 2016; 11(6):e0158169. PubMed ID: 27355513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
    Højen JF; Rasmussen TA; Andersen KL; Winckelmann AA; Laursen RR; Gunst JD; Møller HJ; Fujita M; Østergaard L; Søgaard OS; Dinarello CA; Tolstrup M
    Mol Med; 2015 Apr; 21(1):337-45. PubMed ID: 25879630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased carotid intima-media thickness associated with antibody responses to varicella-zoster virus and cytomegalovirus in HIV-infected patients.
    Masiá M; Robledano C; Ortiz de la Tabla V; Antequera P; López N; Gutiérrez F
    PLoS One; 2013; 8(5):e64327. PubMed ID: 23717597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.